News

NicOx has signed an agreement with Pfizer to reacquire the full development and commercialization rights to PF-03187207, which has completed two phase II studies in patients with primary open-angle glaucoma and ocular hypertension, according to a prepared statement.

Santen Inc. has announced the establishment of a satellite office in Irvine, CA, which will be the base of operations for its business development staff.

A new report from the National Commission on Vision and Health concludes that even though universal comprehensive eye exams for children conducted prior to starting school would result in more vision problems and eye diseases being diagnosed and treated successfully in children, requirements vary widely from state to state, and only three states require eye examinations for school-aged children.

The FDA announced that four botulinum toxin drug products now have boxed warnings on their labels and include medication guides that explain the risk of adverse events to patients, as directed by the agency in April.

Ambulatory centers performing cataract extraction with lens insertion can reduce their procedure times and improve efficiencies, safety, and patient satisfaction, according to a survey conducted by the Accreditation Association for Ambulatory Health Care Institute for Quality Improvement.

Jeffrey Gilbard, MD, founder and chief executive officer of Advanced Vision Research, died Aug. 12 at Massachusetts General Hospital, Boston, following complications related to a bicycle accident. He was 55.

A dual-linear phacoemulsification platform (available on the Stellaris, Bausch & Lomb) separates phaco and vacuum, allowing cataract surgeons to maximize their control over the cataract removal procedure.

As members of Congress return home for August recess, the nation's dialogue continues over how best to provide health-care coverage to 44 million uninsured Americans.

The large variety of available OVDs allows the surgeon to tailor the surgery to meet any specific needs a patient may have.

A new phaco tip (Fine OZil Tip, MicroSurgical Technology) for use with a proprietary handpiece (OZil, Alcon Laboratories) improves the safety and efficiency of phacoemulsification using torsional ultrasound with a biaxial microincisional technique. Modification of the phaco parameters improves chopping and segment removal.

Two prominent cornea specialists have been appointed chairmen of ophthalmology departments in Miami and New York City.

An ophthalmic viscosurgical device of 2.3% sodium hyaluronate (Healon 5, Abbott Medical Optics) makes one ophthalmologist's prechopping-assisted phacoemulsification technique safer and easier, he says.

The belief that truly new experiences become less common as one gets older and, therefore, life becomes more predictable, is one that this doctors thinks is commonly held. But a surprising event happens while on a flight home to challenge this.

Surgeons discuss their preferences and techniques for using various ophthalmic viscosurgical devices in eyes with intraoperative floppy iris syndrome.

The most recent results from the 2008 American Society of Cataract and Refractive Surgery/European Society of Cataract and Refractive Surgeons survey on foldable IOLs requiring removal or other secondary intervention highlight changes over time in the complications associated with various lens types.

The current version of a proprietary phaco system (WhiteStar Signature, Abbott Medical Optics) features fluidics control software that allows automatic switching from longitudinal ultrasound to transversal (Ellips) on recognition of occlusion and back again to longitudinal on occlusion break. Results of a prospective study show the benefits of this technology for optimizing the efficiency of cataract removal.

Ketorolac tromethamine 0.45% (Acuvail, Allergan) is a preservative-free ophthalmic NSAID recently approved for twice-daily use in treating pain and inflammation after cataract surgery. Its novel formulation is designed to promote drug delivery and tolerability.

Researchers are looking into corneal biomechanics as a means to screen patients for keratectasia. An expert reviews signal interpretation from a non-contact applanation tonometer as it relates to corneal biomechanical indices such as corneal hysteresis and also discusses improved signal patterns that may result in more meaningful corneal biomechanical analysis than previously proposed metrics.

NicOx announced an agreement to reacquire the development and commercialization rights to an experimental glaucoma medicine from partner company Pfizer.

In a study conducted by the Pan-American Collaborative Retina Study Group, treatment of diffuse diabetic macular edema with bevacizumab (Avastin, Genentech) was shown to improve vision.

NeoVista Inc. received approval from BSI Product Services to apply the CE mark to its anti-neovascular (ANV) therapy system (Vidion) to treat wet age-related macular degeneration (AMD), the company announced.

The spherical aberration-free lens has been developed specifically for 1.8-mm microincision cataract surgery (MICS), and the company said it will refer to the lens within the United States as the Akreos MICS. Its award-winning design and glistening-free material allow implantation through a 1.8-mm incision, while maintaining the optical quality and stability established with the parent lens design (Akreos AO).

Pat Cummings, OD, Vistakon America's region vice president, professional development group, was killed in a plane crash July 11 in Florida.

Japanese authorities have granted WaveLight AG regulatory approval to market its 200-Hz excimer laser system (Allegretto Wave) for use in wavefront-optimized LASIK treatments of myopia and myopic astigmatism there, according to the company.

SOLX has received clearance from Health Canada for the use of its 24-karat gold implant (SOLX Gold Shunt) during glaucoma surgery.

The FDA will resume scientific review of the STAAR Surgical Co. premarket approval (PMA) application for its toric implantable contact lens ([TICL]; Visian Toric Implantable Collamer Lens) for patients with myopia and astigmatism after removing the "integrity hold" restrictions it put in place in 2007, according to the company.

Alcon Inc. has entered into a 5-year collaborative research agreement with AstraZeneca for the exclusive ophthalmic discovery and potential development rights to AstraZeneca's compound library.

Bausch & Lomb has opened a new 30,000-square-foot global pharmaceutical headquarters building in Madison, NJ.